Wells Fargo & Company Cytokinetics Inc Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Cytokinetics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 73,966 shares of CYTK stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,966

Previous 73,782 0.25%

Holding current value

$2.54 Million

Previous $3.47 Million 14.35%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$40.19 - $51.12 $7,394 - $9,406	184 Added 0.25%	73,966 $2.97 Million
Q4 2024 Feb 12, 2025	BUY	$46.36 - $58.62 $753,257 - $952,457	16,248 Added 28.24%	73,782 $3.47 Million
Q3 2024 Nov 13, 2024	BUY	$51.22 - $60.16 $175,479 - $206,108	3,426 Added 6.33%	57,534 $3.04 Million
Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $643,429 - $1.01 Million	13,444 Added 33.06%	54,108 $2.93 Million
Q1 2024 May 10, 2024	BUY	$63.75 - $108.06 $244,162 - $413,869	3,830 Added 10.4%	40,664 $2.85 Million
Q4 2023 Feb 09, 2024	SELL	$26.88 - $83.49 $1.28 Million - $3.97 Million	-47,596 Reduced 56.37%	36,834 $3.08 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $537,173 - $667,546	-18,234 Reduced 17.76%	84,430 $2.49 Million
Q2 2023 Aug 15, 2023	BUY	$32.62 - $40.75 $952,275 - $1.19 Million	29,193 Added 39.73%	102,664 $3.35 Million
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $1.62 Million - $2.22 Million	48,592 Added 195.31%	73,471 $2.59 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $39,955 - $57,089	1,117 Added 4.7%	24,879 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $28,326 - $40,072	-735 Reduced 3.0%	23,762 $1.15 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $2.86 Million - $4.13 Million	-84,324 Reduced 77.49%	24,497 $963,000
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $284,165 - $439,530	-9,555 Reduced 8.07%	108,821 $4.01 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $1.22 Million - $1.65 Million	35,643 Added 43.08%	118,376 $5.4 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $736,019 - $1.42 Million	39,699 Added 92.25%	82,733 $2.96 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $772,284 - $1.05 Million	-39,024 Reduced 47.56%	43,034 $852,000
Q1 2021 May 13, 2021	SELL	$18.57 - $25.68 $1.41 Million - $1.95 Million	-75,844 Reduced 48.03%	82,058 $1.91 Million
Q4 2020 Feb 09, 2021	BUY	$15.26 - $28.61 $525,584 - $985,385	34,442 Added 27.9%	157,902 $3.28 Million
Q3 2020 Nov 05, 2020	SELL	$20.58 - $28.96 $177,481 - $249,751	-8,624 Reduced 6.53%	123,460 $2.67 Million
Q2 2020 Aug 13, 2020	BUY	$11.15 - $24.64 $107,630 - $237,849	9,653 Added 7.88%	132,084 $3.11 Million
Q1 2020 May 14, 2020	BUY	$8.75 - $16.3 $1.07 Million - $2 Million	122,431 New	122,431 $1.44 Million

Others Institutions Holding CYTK

# of Institutions

385

Shares Held

125M

Call Options Held

3.77M

Put Options Held

1.04M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.23B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cytokinetics Inc Transaction History